Kirill Dmitriyev, the head of Russian Direct Investment Fund (RDIF) which financed the development of the two-dose Sputnik V jab, reacts to the internationally peer reviewed data published in The Lancet, saying that "Sputnik V is the vaccine for mankind". Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to results published in The Lancet that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out.